163,805 Shares in Agilent Technologies, Inc. $A Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 163,805 shares of the medical research company’s stock, valued at approximately $21,758,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vega Investment Solutions acquired a new position in shares of Agilent Technologies during the second quarter worth $1,386,000. Cibc World Market Inc. acquired a new stake in Agilent Technologies in the second quarter valued at $3,814,000. OMERS ADMINISTRATION Corp bought a new position in Agilent Technologies during the 2nd quarter worth $2,220,000. Osmosis Investment Management UK Ltd bought a new position in Agilent Technologies during the 2nd quarter worth $7,127,000. Finally, Sanctuary Advisors LLC acquired a new position in Agilent Technologies during the 2nd quarter worth about $1,462,000.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. TD Cowen increased their price target on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday. Piper Sandler assumed coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. The Goldman Sachs Group upped their target price on Agilent Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a report on Thursday. Finally, Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $170.33.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
• Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
• Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Agilent Technologies Stock Performance

Shares of A opened at $157.60 on Friday. The firm’s fifty day simple moving average is $139.76 and its two-hundred day simple moving average is $126.85. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $163.75. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $44.51 billion, a P/E ratio of 31.02, a price-to-earnings-growth ratio of 2.74 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.84% and a net margin of 19.53%.The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the business earned $1.37 EPS. The firm’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.